Noam Shani
CEO
Pharmaceuticals
KAHR Medical Ltd
Israel
Biography
Before joining KAHR Medical in mid 2007, Dr. Shani was Vice President of R&D for Medgenics (AIM: MEDG) and for Compugen (NASDAQ: CGEN). Dr. Shani received both his master's and Ph.D. from the Weizmann Institute of Science, and did his postdoctoral research fellowships at the Johns Hopkins School of Medicine in Baltimore
Research Interest
Research & Development
